|
KBTBD7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.44089209850063E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.39540001775629E-09 |
| Normal-vs-Stage2 |
1.69470000255245E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.068790E-01 |
| Stage1-vs-Stage3 |
4.47390000000158E-05 |
| Stage1-vs-Stage4 |
5.70570000024695E-07 |
| Stage2-vs-Stage3 |
1.672630E-01 |
| Stage2-vs-Stage4 |
1.618000E-02 |
| Stage3-vs-Stage4 |
1.755760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6251444634463E-12 |
| Normal-vs-AfricanAmerican |
1.43099998517471E-09 |
| Normal-vs-Asian |
9.568600E-01 |
| Caucasian-vs-AfricanAmerican |
2.251000E-01 |
| Caucasian-vs-Asian |
9.317700E-03 |
| AfricanAmerican-vs-Asian |
1.015830E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.99329450115238E-11 |
| Male-vs-Female |
6.541800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.358900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.49430467999423E-11 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
5.97989999739923E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.120800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.751200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.350000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.649900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.139000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.513000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.324600E-01 |
| Normal-vs-Grade 2 |
1.36309996623396E-09 |
| Normal-vs-Grade 3 |
1.62492241884138E-12 |
| Normal-vs-Grade 4 |
1.62458935193399E-12 |
| Grade 1-vs-Grade 2 |
2.068600E-01 |
| Grade 1-vs-Grade 3 |
1.627990E-02 |
| Grade 1-vs-Grade 4 |
1.01959999998513E-06 |
| Grade 2-vs-Grade 3 |
4.938000E-03 |
| Grade 2-vs-Grade 4 |
1.37669986521871E-10 |
| Grade 3-vs-Grade 4 |
4.2160999999985E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.11709999992694E-07 |
| Normal-vs-ccB subtype |
1.62447832963153E-12 |
| ccA subtype-vs-ccB subtype |
1.19510000007317E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.23945339839338E-14 |
| Normal-vs-N1 |
1.236450E-03 |
| N0-vs-N1 |
3.154800E-01 |
|
|
